NEWARK, Del. – March 10, 2022 — ILC Dover LP (“ILC Dover” or the “Company”), specializing in innovative single-use and chemical workflow solutions for biotherapeutics and pharmaceutical processing, announced plans to significantly expand production capabilities in its Juarez, Mexico facility. This expansion is in response to the Company’s unprecedented growth in its life sciences business and entry into sterile liquid handling and chemicals content market. This investment will generate additional production capacity for its single-use powder storage, single-use fluid storage, and fluid transfer solutions and is scheduled to come online later this year.It also dovetails with recent acquisitions of critical sterile liquid production to provide broader workflow solutions for the Company’s growing customer base.
The expansion in Juarez will complement the current global manufacturing footprint in Frederica DE, Durham NC, Stockport UK, Rossens Switzerland, and Blarney Ireland for its pharma and biotherapeutics customers.
“Expansion in Juarez is an investment in our customers’ success and the next step in ILC Dover’s global growth journey. It strengthens our partnership with key pharmaceutical and biotherapeutics customers around the world — solidifying our ability to expand our presence in critical products for life-saving therapies, improve lead times, and securing our customers’ supply chain in North America,” said Corey Walker, CEO of ILC Dover. “Most importantly, this expansion strengthens our position as a valuable and vertically integrated partner for our life science customers — supporting customers to continue to improve and optimize their workflows.”
Operational in Mexico since 2013, the addition of 20,000 sq ft of new Class 6 and 7 clean room space will support multi-site production of solutions for the biotherapeutic, cell & gene therapy, and pharmaceutical markets. ILC Dover’s Juarez site will use the same processes, raw materials, and equipment as other sites in the global network to provide redundant supply and reduced lead times for customers — consistent with the Company’s global quality system.
This most recent expansion showcases ILC Dover’s commitment to growing its life science solutions for its global customer base. The Company acquired two strategic businesses this past year to accelerate its trajectory in critical life science applications: sterile solutions manufacturer KSE Scientific and medical contract design and manufacturing company Flexan. The proven capabilities and synergies offered with the addition of both companies enable ILC Dover to link single-use solutions and chemical solutions across its customers’ workflows.
###
About ILC Dover
ILC Dover is a world-leader in the innovative design and production of solutions for biopharmaceutical, pharmaceutical, medical device markets as well as a leading supplier for the (aero)space industries. Our customers will attest to our relentless dedication to high value products, advanced technology, and responsive service, as our visionary solutions have improved efficiency while safeguarding people, product, and infrastructure in hazardous conditions through flexible protective solutions since 1947. For more information on ILC Dover, please visit www.ilcdover.com.
About New Mountain Capital
New Mountain Capital is a New York-based investment firm that emphasizes business building and growth, rather than debt, as it pursues long-term capital appreciation. The firm currently manages private equity, public equity, and credit funds with over $35 billion in assets under management. New Mountain seeks out what it believes to be the highest quality growth leaders in carefully selected industry sectors and then works intensively with management to build the value of these companies. For more information on New Mountain Capital, please visit www.newmountaincapital.com.
